More issues

How to Get Upstaza (Kebilidi) Covered by Aetna CVS Health in Illinois: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Upstaza Covered by Aetna CVS Health in Illinois Aetna CVS Health requires prior authorization for Kebilidi (eladocagene exuparvovec) through their Gene-Based, Cellular, and Other Innovative Therapies (GCIT) network. Standard review takes 30-45 days; expedited requests process within 72 hours. Three-step path: (1) Confirm genetic testing shows biallelic
6 min read

If Cresemba (Isavuconazole) Isn't Approved by UnitedHealthcare in California: Formulary Alternatives & Exception Paths

Answer Box: When Cresemba Gets Denied If UnitedHealthcare denies Cresemba (isavuconazole) in California, you have three main paths: try a formulary alternative like voriconazole, request a formulary exception with clinical documentation, or file an internal appeal within 65 days. Most denials stem from prior authorization requirements or step therapy—both
6 min read

Renewing Xenpozyme (Olipudase Alfa) Approval with Cigna in Pennsylvania: 2025 Requirements, Timeline & Bridge Options

Answer Box: Xenpozyme Renewal with Cigna in Pennsylvania Cigna typically requires annual renewal for Xenpozyme (olipudase alfa-rpcp) with documentation of sustained clinical benefit in ASMD. Start your renewal 60-90 days before expiration to avoid treatment gaps. Submit through your specialist with updated clinical response data (spleen/liver measurements, pulmonary function
6 min read

How to Get Kymriah (tisagenlecleucel) Covered by Blue Cross Blue Shield in Georgia: Prior Authorization, Appeals, and Cost Assistance

Answer Box: Getting Kymriah Covered in Georgia Kymriah (tisagenlecleucel) is covered by Blue Cross Blue Shield plans in Georgia but requires prior authorization and treatment at certified CAR-T centers. The fastest path to approval: (1) Confirm CD19-positive diagnosis with pathology reports, (2) Document failed prior therapies, and (3) Submit prior
6 min read